Breast implants can give you a fuller, more shapely bustline. Choose from silicon or saline, either of which can be placed above or below the chest muscle. Find more information about types of implants, safety and risks, and more.
Surgery to Lose Fat, Get Bigger Breasts? A technique known as breast enhancement with fat grafts or lipoaugmentation is showing promise, according to a panel of plastic surgeons at the annual meeting of the American Society for Aesthetic Plastic Surgery in San Diego. Even so, they acknowledge that some concerns and questions remain to be resolved.
FDA Questions Studies of Breast Implant Safety A panel of expert advisors to the FDA has been asked to solve a mystery: What happened to thousands of women who enrolled in studies designed to evaluate rare complications that might arise years after they received silicone gel breast implants?
FDA: Silicone Breast Implants Don't Last a Lifetime A new report from the FDA shows that 20% of women who get silicone gel implants to increase the size of their breasts, and half of all women who get them for breast reconstruction, will have those implants removed within a decade, often because of complications like breast hardening or rupture.
Silicone Breast Implants: New Concerns One month after the FDA approved the return of silicone breast implants to the U.S. market, a European study is raising new concerns about their safety.
Breast Implants Back on the Front Pages A new chapter in the ongoing saga of breast implant safety is about to unfold as an expert advisory committee to the FDA will meet in March to discuss the best ways to study the long-term effects of implants.
Backers Savor FDA Saline Breast Implant Approval After a battle that raged throughout the '90s, proponents of saline breast implants finally won their fight to get the controversial products approved by the FDA, but that didn't end the war.
Breast Implant Safety Incomplete A report issued Friday cautions against the likely return of silicone breast implants to the U.S. market, warning that companies have not performed long-term safety studies in breast cancer patients.